Literature DB >> 21307362

Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis.

Alejandro R Chade1.   

Abstract

Emerging evidence supports the pivotal role of renal microvascular disease as a determinant of tubulo-interstitial and glomerular fibrosis in chronic kidney disease. An intact microcirculation is vital to restore blood flow to the injured tissues, which is a crucial step to achieve a successful repair response. The purpose of this review is to discuss the impact and mechanisms of the functional and structural changes of the renal microvascular network, as well as the role of these changes in the progression and irreversibility of renal injury. Damage of the renal microcirculation and deterioration of the angiogenic response may constitute early steps in the complex pathways involved in progressive renal injury. There is limited but provocative evidence that stimulation of vascular proliferation and repair may stabilize renal function and slow the progression of renal disease. The feasibility of novel potential therapeutic interventions for stabilizing the renal microvasculature is also discussed. Targeted interventions to enhance endogenous renoprotective mechanisms focused on the microcirculation, such as cell-based therapy or the use of angiogenic cytokines have shown promising results in some experimental and clinical settings.

Entities:  

Mesh:

Year:  2011        PMID: 21307362      PMCID: PMC3075083          DOI: 10.1152/ajpregu.00657.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  77 in total

1.  Podocytes and the development of segmental glomerulosclerosis.

Authors:  M Elger; W Kriz
Journal:  Nephrol Dial Transplant       Date:  1998-06       Impact factor: 5.992

2.  Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.

Authors:  T D Henry; K Rocha-Singh; J M Isner; D J Kereiakes; F J Giordano; M Simons; D W Losordo; R C Hendel; R O Bonow; S M Eppler; T F Zioncheck; E B Holmgren; E R McCluskey
Journal:  Am Heart J       Date:  2001-11       Impact factor: 4.749

3.  VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts.

Authors:  Toshihiro Shimizu; Hiroshi Okamoto; Satoru Chiba; Yutaka Matsui; Takeshi Sugawara; Masatoshi Akino; Jia Nan; Hideki Kumamoto; Hisao Onozuka; Taisei Mikami; Akira Kitabatake
Journal:  Cardiovasc Res       Date:  2003-04-01       Impact factor: 10.787

4.  Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study.

Authors:  Johan Lorenzen; Sascha David; Ferdinand H Bahlmann; Kirsten de Groot; Elisabeth Bahlmann; Jan T Kielstein; Hermann Haller; Danilo Fliser
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

5.  Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytes.

Authors:  Kaustubh Datta; Jinping Li; S Ananth Karumanchi; Enfeng Wang; Eric Rondeau; Debabrata Mukhopadhyay
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

Review 6.  Ischemic nephropathy: where are we now?

Authors:  Stephen C Textor
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

Review 7.  Angiogenesis in the kidney: a new therapeutic target?

Authors:  Lilach O Lerman; Alejandro R Chade
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-03       Impact factor: 2.894

Review 8.  Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics.

Authors:  Leon G Fine; Jill T Norman
Journal:  Kidney Int       Date:  2008-07-16       Impact factor: 10.612

9.  Combined administration of naked DNA vectors encoding VEGF and bFGF enhances tissue perfusion and arteriogenesis in ischemic hindlimb.

Authors:  Jung-Sun Lee; Jeong-Min Kim; Koung Li Kim; Hyung-Suk Jang; In-Soon Shin; Eun-Seok Jeon; Wonhee Suh; Jonghoe Byun; Duk-Kyung Kim
Journal:  Biochem Biophys Res Commun       Date:  2007-07-03       Impact factor: 3.575

10.  Endothelial progenitor cells in patients with coronary artery disease and left ventricular dysfunction.

Authors:  Francesco Pelliccia; Vincenzo Pasceri; Cinzia Cianfrocca; Cristiana Vitale; Christian Pristipino; Giulio Speciale; Giuseppe Mercuro; Giuseppe Rosano
Journal:  Coron Artery Dis       Date:  2009-08       Impact factor: 1.439

View more
  19 in total

1.  The unfolded protein response regulates an angiogenic response by the kidney epithelium during ischemic stress.

Authors:  Nicolas Bouvier; Sophie Fougeray; Philippe Beaune; Eric Thervet; Nicolas Pallet
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

Review 2.  Development of the renal arterioles.

Authors:  Maria Luisa S Sequeira Lopez; R Ariel Gomez
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

Review 3.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 4.  Potential approaches to reverse or repair renal fibrosis.

Authors:  Desiree Tampe; Michael Zeisberg
Journal:  Nat Rev Nephrol       Date:  2014-02-11       Impact factor: 28.314

5.  The Kidney Dysfunction Epidemic, Part 2: Intervention.

Authors:  Joseph Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2016-03

6.  Atherosclerotic renal artery stenosis is associated with elevated cell cycle arrest markers related to reduced renal blood flow and postcontrast hypoxia.

Authors:  Ahmed Saad; Wei Wang; Sandra M S Herrmann; James F Glockner; Michael A Mckusick; Sanjay Misra; Haraldur Bjarnason; Lilach O Lerman; Stephen C Textor
Journal:  Nephrol Dial Transplant       Date:  2016-07-29       Impact factor: 5.992

7.  Hedgehog-Gli pathway activation during kidney fibrosis.

Authors:  Steven L Fabian; Radostin R Penchev; Benoit St-Jacques; Anjali N Rao; Petra Sipilä; Kip A West; Andrew P McMahon; Benjamin D Humphreys
Journal:  Am J Pathol       Date:  2012-02-17       Impact factor: 4.307

Review 8.  Mitochondria: a pathogenic paradigm in hypertensive renal disease.

Authors:  Alfonso Eirin; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2014-11-17       Impact factor: 10.190

Review 9.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

Review 10.  Remnant nephron physiology and the progression of chronic kidney disease.

Authors:  H William Schnaper
Journal:  Pediatr Nephrol       Date:  2013-05-29       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.